Dipyridamole plus aspirin significantly reduced platelet deposition in saphenous vein bypass grafts in dogs compared to controls (graft-to-blood radioactivity ratio 5 vs 17, p<0.01).
Does dipyridamole plus aspirin reduce platelet deposition in saphenous vein bypass grafts in a canine model?
A noninvasive radioisotopic technique using indium-111 labeled platelets successfully detected platelet deposition in canine saphenous vein bypass grafts, demonstrating significant reduction with dipyridamole and aspirin therapy.
Absolute Event Rate: 5% vs 17%
p-value: p=<0.01
At 8 and 32 hours after saphenous vein bypass graft surgery in six dogs, in vivo images of the graft were obtained with a gamma camera after intravenous injection, 2 hours postoperatively of autologous platelets labeled with indium-111. Platelet deposition in the grafts could be imaged in vivo from the scintiphotos. In vitro images of the excised heart showed saphenous vein graft uptake confirming the in vivo image. In vitro determination of radioactivity in the graft averaged 17 +/- 14 times greater than in blood and 33 +/- 26 times greater than in the lung. Under identical conditions, in eight dogs treated with dipyridamole (55 mg/day) plus aspirin (325 mg/day), the grafts appeared to have considerably less platelet deposition as estimated by imaging. In vitro determination of radioactivity in the graft averaged 5 +/- 2 times greater than in blood and 8 +/- 4 times greater than in the lung (p less than 0.01). This noninvasive technique may be a promising tool for a better understanding of the role played by platelets in the process of occlusion of saphenous vein bypass grafts in man and its prevention with platelet inhibotors.
Fuster et al. (Sat,) conducted a other in Platelet deposition in saphenous vein bypass grafts (n=14). Dipyridamole plus aspirin vs. Control (no treatment) was evaluated on In vitro determination of radioactivity in the graft compared to blood (p=<0.01). Dipyridamole plus aspirin significantly reduced platelet deposition in saphenous vein bypass grafts in dogs compared to controls (graft-to-blood radioactivity ratio 5 vs 17, p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: